wire

Men at risk of cardiovascular disease may develop cognitive conditions up to a decade before similarly at-risk women A study using UK Biobank data has found that high cardiovascular risk factors, including obesity, are linked to accelerated brain volume loss, affecting the regions in the temporal lobe that are crucial for memory and sensory processing.

In a new study, scientists from our top-rated Biosciences department joined forces with researchers from Jagiellonian University (Poland), and the John Innes Centre to reveal how a bacterial enzyme called DNA gyrase twists and stabilises DNA.

A loss of brain volume associated with new immunotherapies for Alzheimer's disease may be caused by the removal of amyloid plaques, rather than the loss of neurons or brain tissue, finds a study led by UCL researchers.

A new type of therapy that 'edits' a gene in patients with a rare heart condition has been shown to be safe and effective, according to research from UCL and the Royal Free Hospital.

Dr Jane Wood has created a fashionable recipe for success; a bit of left over tea and sugar, mixed with kombucha starter culture and she's able to produce vegetable leather. In 2015, Jane Wood was a senior lecturer at Manchester Metropolitan University. She taught across a variety of fashion related programmes and loved chatting to students as they often came up with novel ways of solving problems encountered in the fashion and textiles industry.

Traditionally, this research has heavily relied on animal testing, but researchers at the Henry Royce Institute at The University of Manchester, are revolutionising this field by using 3D printing technology to create sophisticated bone models in the laboratory.

Enzymes are nature's catalysts, they make life possible. Their catalytic power is the basis of the current biotechnology revolution; yet, our understanding of enzymes remains limited by their intrinsic complexity.

Care for stroke survivors urgently needs to focus on non-motor skill outcomes like fatigue, anxiety and reduced social participation to improve survivors' quality of life and minimise care needs, according to a new study by researchers at UCL and UCLH. The study, published in the Lancet Regional Health - Europe, is the first to comprehensively capture the wide-ranging impacts of non-motor skill outcomes in a large group of patients.

A researcher from The University of Manchester has bagged a prize for developing a powerful way to minimize suffering in animals when studying kidney disease.

A new treatment that could prevent blindness in children with the CLN2 type Batten disease has been trialled by clinicians and researchers at UCL and Great Ormond Street Hospital (GOSH).

Here's a batch of fresh news and announcements from across Imperial. From cheating sparrows to plant defences and award winning computer scientists, here is some quick-read news from across Imperial.

Researchers at UCL and the Francis Crick Institute have embarked on a study to establish a causal link between air pollution and neurodegeneration. The new project, called the R ole of Air Pollution in Dementia ( RAPID), will examine the effect of tiny pollutant particles on the body's immune response and subsequent disease development.

A new artificial intelligence (AI) tool developed by researchers at UCL and UCLH can analyse scans more quickly than experienced neurologists and provide greater patient-personalised detail to aid treatment.

Here's a batch of fresh news and announcements from across Imperial. From a report on biometric data collection to the invasion tactics of the potato blight pathogen, here is some quick-read news from across Imperial.

The ongoing loss of bird species is likely to have severe knock-on effects as their unique roles in ecosystems are not fulfilled, shows a new study.

The first wiring diagram of every neuron in an adult brain and the 50 million connections between them has been produced for a fruit fly. Brain wiring diagrams are a first step towards understanding everything we're interested in - how we control our movement, answer the telephone, or recognise a friend.

Researchers extend study on exploring markers associated with Alzheimer's disease thanks to an exceptional donation from Gates Ventures. A research team at Imperial College London, led by Professor Lefkos Middleton has received a philanthropic gift from Gates Ventures to pursue a three-year research programme aimed at uncovering risk factors and markers of Alzheimer's disease.

INBRAIN Neuroelectronics , a brain-computer interface therapeutics (BCI-Tx) company pioneering graphene-based neural technologies, announced today the world's first human procedure of its corticaI interface in a patient undergoing brain tumor resection.

Results of a world-first phase 3 trial for secondary progressive multiple sclerosis (MS), led by UCL researchers, have shown that the commonly used high-cholesterol drug simvastatin cannot slow disability progression. The results, announced at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) conference in Copenhagen, followed promising phase 2 trial findings.